💊Drugs and candidates
Every medicine linked to renal cell carcinoma, by how far it has got
Approved · 20
AldesleukinInterleukin-2 receptor agonistApproved
AxitinibVascular endothelial growth factor receptor inhibitorApproved
BelzutifanEndothelial PAS domain-containing protein 1 inhibitorApproved
BevacizumabVascular endothelial growth factor A inhibitorApproved
CabozantinibVascular endothelial growth factor receptor 2 inhibitor; Hepatocyte growth factor recepto…Approved
Cabozantinib S-MalateVascular endothelial growth factor receptor 2 inhibitor; Hepatocyte growth factor recepto…Approved
Show all 20
EverolimusFK506-binding protein 1A inhibitorApproved
IpilimumabCytotoxic T-lymphocyte protein 4 inhibitorApproved
LenvatinibVascular endothelial growth factor receptor inhibitorApproved
Lenvatinib MesylateVascular endothelial growth factor receptor inhibitorApproved
NivolumabProgrammed cell death protein 1 inhibitorApproved
PazopanibMacrophage colony stimulating factor receptor inhibitor; Stem cell growth factor receptor…Approved
Pazopanib HydrochlorideMacrophage colony stimulating factor receptor inhibitor; Stem cell growth factor receptor…Approved
PembrolizumabProgrammed cell death protein 1 inhibitorApproved
SifalimumabInterferon alpha inhibitorApproved
SorafenibSerine/threonine-protein kinase RAF inhibitor; Platelet-derived growth factor receptor be…Approved
Sorafenib TosylateSerine/threonine-protein kinase RAF inhibitor; Platelet-derived growth factor receptor be…Approved
SunitinibMacrophage colony stimulating factor receptor inhibitor; Stem cell growth factor receptor…Approved
Sunitinib MalateMacrophage colony stimulating factor receptor inhibitor; Stem cell growth factor receptor…Approved
TemsirolimusFK506-binding protein 1A inhibitorApproved
In phase 2 / 3 · 20
Coagulation Factor X HumanCoagulation factor X exogenous proteinFiled for approval
AbexinostatHistone deacetylase inhibitorPhase 3
AtezolizumabProgrammed cell death 1 ligand 1 inhibitorPhase 3
AvelumabProgrammed cell death 1 ligand 1 otherPhase 3
BenmelstobartPhase 3
CapecitabineThymidylate synthase inhibitorPhase 3
Show all 20
CatequentinibVascular endothelial growth factor receptor 2 inhibitor; Vascular endothelial growth fact…Phase 3
Catequentinib HydrochloridePhase 3
CyclophosphamidePhase 3
DenosumabTumor necrosis factor ligand superfamily member 11 inhibitorPhase 3
DovitinibFibroblast growth factor receptor 3 inhibitor; Tyrosine-protein kinase receptor FLT3 inhi…Phase 3
DurvalumabProgrammed cell death 1 ligand 1 inhibitorPhase 3
EpacadostatIndoleamine 2,3-dioxygenase inhibitorPhase 3
FluorouracilThymidylate synthase inhibitorPhase 3
InterferonPhase 3
Interferon AlfaPhase 3
Interferon Alfa-2AInterferon alpha/beta receptor agonistPhase 3
Interferon Alfa-2BInterferon alpha/beta receptor agonistPhase 3
IsotretinoinRetinoic acid receptor agonistPhase 3
Latanoprostene BunodProstanoid FP receptor agonistPhase 3
Early trials · 20
AdebrelimabProgrammed cell death 1 ligand 1 inhibitorPhase 1/2
Agatolimod SodiumToll-like receptor 9 agonistPhase 1/2
Apl-501Programmed cell death protein 1 inhibitorPhase 1/2
AzacitidineDNA (cytosine-5)-methyltransferase 3A inhibitor; DNA (cytosine-5)-methyltransferase 1 inh…Phase 1/2
BempegaldesleukinPhase 1/2
BexmarilimabPhase 1/2
Show all 20
BicalutamideAndrogen Receptor antagonistPhase 1/2
Cdx-014Phase 1/2
CetuximabEpidermal growth factor receptor erbB1 inhibitorPhase 1/2
CiforadenantAdenosine A2a receptor antagonistPhase 1/2
CintirorgonPhase 1/2
DactolisibSerine/threonine-protein kinase mTOR inhibitor; PI3-kinase class I inhibitorPhase 1/2
Denileukin DiftitoxElongation factor 2 inhibitor; Interleukin-2 receptor binding agentPhase 1/2
DocetaxelTubulin inhibitorPhase 1/2
EtaracizumabIntegrin alpha-V/beta-3 antagonistPhase 1/2
FavezelimabLymphocyte activation gene 3 protein inhibitorPhase 1/2
GimistotugPhase 1/2
Gti-2040Ribonucleotide reductase small subunit mRNA antisense inhibitorPhase 1/2
Human Immunoglobulin GPhase 1/2
Hyaluronidase (Human Recombinant)Phase 1/2
HealthTeky